BTFL — Bountiful Co Income Statement
0.000.00%
HealthcareMicro Cap
Annual income statement for Bountiful Co, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2018 September 30th | 2019 September 30th | 2020 September 30th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 1,900 | 1,882 | 2,069 |
| Cost of Revenue | |||
| Gross Profit | 612 | 682 | 793 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 1,878 | 1,894 | 1,872 |
| Operating Profit | 22.4 | -12.3 | 197 |
| Gain / Loss on Sale of Assets | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -110 | -152 | 81.6 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 158 | -114 | 69.9 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | 156 | -114 | 69.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 156 | -114 | 69.9 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 35.8 | -3.56 | 15.2 |
| Dividends per Share |